Expression of cytochrome P450 in lung tumor

被引:21
作者
Gharavi, N [1 ]
El-Kadi, AOS [1 ]
机构
[1] Univ Alberta, Fac Pharm & Pharmaceut Sci, Dent Pharm Ctr 3118, Edmonton, AB T6G 2N8, Canada
关键词
anticancer drugs; cytochrome P450; drug metabolizing enzymes; cancer; lung; tumor;
D O I
10.2174/1389200043489045
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytochrome P450 (CYP450) enzymes have the capability of playing key metabolic roles in several aspects of cancer as a consequence of their unusually broad Substrate specificities. CYP450 are also prominent players in the metabolism of anticancer therapeutic drugs, enhancing or diminishing the efficacy of the drugs depending oil whether the drug Or its metabolites are efficacious. As CYP450 enzymes are also found ill lung tissue, lung metabolism can be of importance to the bioactivation of some anticancer agents. The presence of individual forms of CYP450 has been investigated in lung tumor to determine whether intra-tumor metabolism of anticancer agents by CYP450 Could Occur and thus influence the response of tumor to these agents. Differences in drug metabolism between normal and cancerous lung tissue have been shown to exist. therefore: the variable expression of CYP450 between tumor and normal tissue call provide a basis for selective sensitivity of tissue to anticancer drugs. thereby localizing drug actions to tumor. This review gives a detailed picture Of the expression of CYP450 ill lung tumor and the role of this enzyme ill lung tumor in the fate of anticancer drugs.
引用
收藏
页码:203 / 210
页数:8
相关论文
共 102 条
[41]   Aflatoxin B-1 activation in human lung [J].
Kelly, JD ;
Eaton, DL ;
Guengerich, FP ;
Coulombe, RA .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1997, 144 (01) :88-95
[42]   The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: Implications for drug interactions [J].
Kivisto, KT ;
Kroemer, HK ;
Eichelbaum, M .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 40 (06) :523-530
[43]  
Kivisto KT, 1996, N-S ARCH PHARMACOL, V353, P207
[44]   IMMUNOHISTOCHEMICAL LOCALIZATION OF CYTOCHROME-P450 3A IN HUMAN PULMONARY CARCINOMAS AND NORMAL BRONCHIAL TISSUE [J].
KIVISTO, KT ;
FRITZ, P ;
LINDER, A ;
FRIEDEL, G ;
BEAUNE, P ;
KROEMER, HK .
HISTOCHEMISTRY AND CELL BIOLOGY, 1995, 103 (01) :25-29
[45]   Analysis of CYP2D6 expression in human lung: Implications for the association between CYP2D6 activity and susceptibility to lung cancer [J].
Kivisto, KT ;
Griese, KU ;
Stuven, T ;
Fritz, P ;
Friedel, G ;
Kroemer, HK ;
Zanger, UM .
PHARMACOGENETICS, 1997, 7 (04) :295-302
[46]  
KIVISTO KT, 1995, VIRCHOWS ARCH, V426, P243
[47]  
Komatsu T, 2000, DRUG METAB DISPOS, V28, P1457
[48]   Expression of CYP2A genes in human liver and extrahepatic tissues [J].
Koskela, S ;
Hakkola, J ;
Hukkanen, J ;
Pelkonen, O ;
Sorri, M ;
Saranen, A ;
Anttila, S ;
Fernandez-Salguero, P ;
Gonzalez, F ;
Raunio, H .
BIOCHEMICAL PHARMACOLOGY, 1999, 57 (12) :1407-1413
[49]   Characterization of cytochrome P450 expression in human oesophageal mucosa [J].
Lechevrel, M ;
Casson, AG ;
Wolf, CR ;
Hardie, LJ ;
Flinterman, MB ;
Montesano, R ;
Wild, CP .
CARCINOGENESIS, 1999, 20 (02) :243-248
[50]   Evidence for CYP2D6 expression in human lung [J].
Lo Guidice, JM ;
Marez, D ;
Sabbagh, N ;
Legrand-Andreoletti, M ;
Spire, C ;
Alcaïde, E ;
Lafitte, JJ ;
Broly, F .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 241 (01) :79-85